INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGL

Core Viewpoint - A class action lawsuit has been filed against Agilon Health, Inc. concerning allegations of securities fraud and unlawful business practices [2]. Group 1: Lawsuit Details - Investors are encouraged to contact Pomerantz LLP for participation in the class action, with a deadline to apply as Lead Plaintiff by March 2, 2026 [2]. - The lawsuit pertains to actions taken by Agilon and certain officers and/or directors during the Class Period [2]. Group 2: Company Performance and Management Changes - On August 4, 2025, Agilon announced the resignation of Steven Sell as President, CEO, and Director of the Board [4]. - The same day, Agilon reported its second-quarter financial results, indicating that industry challenges were more severe than anticipated, leading to the suspension of its full-year 2025 financial guidance [4]. - Following these announcements, Agilon's stock price dropped by $0.94 per share, or 51.52%, closing at $0.88 per share on August 5, 2025 [4].